We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Buys

Rank Stock Value
1
RMD icon
ResMed
RMD
+$52.9M
2
WST icon
West Pharmaceutical
WST
+$39.7M
3
AMED
Amedisys
AMED
+$36.8M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$34M
5
SPOT icon
Spotify
SPOT
+$34M

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
201
Amgen
AMGN
$208B
$19.5M 0.15%
82,608
-4,419
-5% -$1.01M
HST icon
202
Host Hotels & Resorts
HST
$17.2B
$19.4M 0.15%
1,794,484
-44,825
-2% -$515K
TGTX icon
203
TG Therapeutics
TGTX
$7.96B
$19.3M 0.15%
+992,041
New +$16M
GNRC icon
204
Generac Holdings
GNRC
$11.6B
$19.1M 0.15%
156,475
-13,100
-8% -$1.38M
PENN icon
205
PENN Entertainment
PENN
$2.75B
$18.9M 0.15%
618,786
– –
MDT icon
206
Medtronic
MDT
$109B
$18.6M 0.14%
202,883
-9,247
-4% -$887K
EBAY icon
207
eBay
EBAY
$50.6B
$18.5M 0.14%
353,350
-10,100
-3% -$427K
ZBRA icon
208
Zebra Technologies
ZBRA
$14B
$18.3M 0.14%
71,682
-25,193
-26% -$5.9M
TPTX
209
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$18.3M 0.14%
+283,362
New +$16.3M
JNJ icon
210
Johnson & Johnson
JNJ
$618B
$17.6M 0.14%
125,352
+9,461
+8% +$1.38M
UNP icon
211
Union Pacific
UNP
$174B
$17.6M 0.14%
103,915
-4,736
-4% -$759K
HQY icon
212
HealthEquity
HQY
$8.41B
$17.5M 0.14%
298,538
+21,098
+8% +$1.17M
VMC icon
213
Vulcan Materials
VMC
$34.8B
$17.4M 0.13%
150,000
-39,150
-21% -$4.29M
CNP icon
214
CenterPoint Energy
CNP
$27.7B
$17.4M 0.13%
+930,025
New +$16M
APD icon
215
Air Products & Chemicals
APD
$65.7B
$17.3M 0.13%
71,556
+23,249
+48% +$5.31M
EHTH icon
216
eHealth
EHTH
$42.2M
$17.3M 0.13%
175,765
-79,216
-31% -$9.21M
CVX icon
217
Chevron
CVX
$392B
$17.3M 0.13%
193,503
-45,640
-19% -$4.09M
CCL icon
218
Carnival Corporation Ltd
CCL
$38.1B
$17.2M 0.13%
+1,050,325
New +$15.7M
PFE icon
219
Pfizer
PFE
$143B
$17M 0.13%
549,504
-25,047
-4% -$851K
XYL icon
220
Xylem
XYL
$27.3B
$17M 0.13%
261,079
-11,875
-4% -$784K
COLD icon
221
Americold
COLD
$4.02B
$16.9M 0.13%
466,525
-19,175
-4% -$655K
LMT icon
222
Lockheed Martin
LMT
$134B
$16.9M 0.13%
46,308
-19,512
-30% -$7.37M
INSP icon
223
Inspire Medical Systems
INSP
$1.45B
$16.6M 0.13%
+190,988
New +$14.7M
PRO
224
DELISTED
PROS Holdings
PRO
$16.5M 0.13%
+372,015
New +$13.1M
AEM icon
225
Agnico Eagle Mines
AEM
$73.6B
$16.5M 0.13%
257,550
-16,400
-6% -$972K
7 8
9
10 11

Similar funds

GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return
HCM
Horan Capital Management Hunt Valley, Maryland $794M AUM 30.86% 1-Year Est. Return
DBC
Deep Basin Capital Stamford, Connecticut $739M AUM 4.75% 1-Year Est. Return

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.